Cambridge Investment Research Advisors
BBH icon

Cambridge Investment Research Advisors’s VanEck Biotech ETF BBH Stock Holding History

Cambridge Investment Research Advisors’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$272K Buy
1,337
+64
+5% +$12K ﹤0.01% 3531
2026
Q1 		$239K Sell
1,273
-203
-14% -$39.1K ﹤0.01% 3497
2025
Q4 		$279K Buy
1,476
+188
+15% +$34.8K ﹤0.01% 3268
2025
Q3 		$213K Buy
+1,288
New +$210K ﹤0.01% 3433
2024
Q4 		– Sell
-1,556
Closed -$276K – 3475
2024
Q3 		$276K Sell
1,556
-34
-2% -$6.03K ﹤0.01% 2889
2024
Q2 		$268K Sell
1,590
-99
-6% -$16.2K ﹤0.01% 2792
2024
Q1 		$281K Buy
1,689
+335
+25% +$55.5K ﹤0.01% 2750
2023
Q4 		$224K Buy
+1,354
New +$208K ﹤0.01% 2821
2023
Q3 		– Sell
-1,549
Closed -$242K – 3148
2023
Q2 		$242K Sell
1,549
-2,649
-63% -$423K ﹤0.01% 2713
2023
Q1 		$680K Sell
4,198
-6,843
-62% -$1.11M ﹤0.01% 1863
2022
Q4 		$1.76M Buy
11,041
+207
+2% +$32.8K 0.01% 1152
2022
Q3 		$1.52M Sell
10,834
-879
-8% -$133K 0.01% 1202
2022
Q2 		$1.71M Sell
11,713
-1,240
-10% -$185K 0.01% 1121
2022
Q1 		$2.1M Buy
12,953
+10,429
+413% +$1.69M 0.01% 1109
2021
Q4 		$478K Buy
2,524
+67
+3% +$12.9K ﹤0.01% 2138
2021
Q3 		$497K Buy
2,457
+344
+16% +$72.2K ﹤0.01% 2063
2021
Q2 		$426K Sell
2,113
-212
-9% -$39.5K ﹤0.01% 2181
2021
Q1 		$408K Sell
2,325
-717
-24% -$130K ﹤0.01% 2043
2020
Q4 		$516K Buy
3,042
+296
+11% +$48.8K ﹤0.01% 1751
2020
Q3 		$445K Sell
2,746
-373
-12% -$60.7K ﹤0.01% 1681
2020
Q2 		$508K Buy
3,119
+1,550
+99% +$236K ﹤0.01% 1548
2020
Q1 		$201K Buy
+1,569
New +$211K ﹤0.01% 1932
2018
Q4 		– Sell
-2,284
Closed -$311K – 2161
2018
Q3 		$311K Sell
2,284
-83
-4% -$10.8K ﹤0.01% 1777
2018
Q2 		$284K Sell
2,367
-269
-10% -$31.7K ﹤0.01% 1766
2018
Q1 		$317K Buy
2,636
+34
+1% +$4.27K ﹤0.01% 1628
2017
Q4 		$324K Sell
2,602
-10,960
-81% -$1.4M ﹤0.01% 1599
2017
Q3 		$1.82M Sell
13,562
-8,011
-37% -$1.04M 0.02% 569
2017
Q2 		$2.71M Sell
21,573
-137
-0.6% -$16.5K 0.04% 409
2017
Q1 		$2.58M Sell
21,710
-729
-3% -$85.3K 0.04% 381
2016
Q4 		$2.41M Sell
22,439
-6,493
-22% -$706K 0.05% 383
2016
Q3 		$3.33M Buy
28,932
+25,639
+779% +$2.92M 0.06% 293
2016
Q2 		$337K Buy
3,293
+450
+16% +$48K 0.01% 1120
2016
Q1 		$295K Sell
2,843
-350
-11% -$36.5K 0.01% 1179
2015
Q4 		$405K Buy
3,193
+4
+0.1% +$490 0.01% 965
2015
Q3 		$365K Sell
3,189
-990
-24% -$131K 0.01% 928
2015
Q2 		$564K Buy
4,179
+570
+16% +$75.8K 0.02% 754
2015
Q1 		$468K Sell
3,609
-124
-3% -$15.6K 0.01% 833
2014
Q4 		$431K Buy
3,733
+247
+7% +$27.8K 0.01% 850
2014
Q3 		$369K Buy
3,486
+76
+2% +$7.69K 0.01% 971
2014
Q2 		$325K Sell
3,410
-966
-22% -$86.6K 0.01% 971
2014
Q1 		$398K Buy
+4,376
New +$425K 0.02% 821

Other funds holding BBH

CCA
Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return
PPWM
Paragon Private Wealth Management Lexington, Kentucky $383M AUM 36.18% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
IFWM
Institute for Wealth Management Denver, Colorado $1.13B AUM 39.73% 1-Year Est. Return
AL
Aspiriant LLC Los Angeles, California $4.05B AUM 19.01% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
PVI
Pine Valley Investments Marlton, New Jersey $2.53B AUM 36.18% 1-Year Est. Return
HFAS
Hummer Financial Advisory Services Chicago, Illinois $152M AUM 20.1% 1-Year Est. Return
VIP
Value Investment Professionals New York $119M AUM

Cambridge Investment Research Advisors's BBH Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its VanEck Biotech ETF (BBH) stake by 5% in Q2 2026, buying an estimated $12K and bringing the position to 1,337 shares worth $272K. The position accounts for ﹤0.01% of the portfolio, ranked #3531.

Cambridge Investment Research Advisors first reported a position in BBH in Q1 2014 and has held it in 41 quarters since. The position peaked at $3.33M in Q3 2016. 31 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

  • Cambridge Investment Research Advisors held 1,337 shares of VanEck Biotech ETF worth $272K as of Q2 2026.
  • Cambridge Investment Research Advisors bought 64 VanEck Biotech ETF shares in Q2 2026, an estimated $12K.
  • VanEck Biotech ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3531 holding.
  • Cambridge Investment Research Advisors first reported a position in VanEck Biotech ETF in Q1 2014 and has held it in 41 quarters since.
  • Cambridge Investment Research Advisors's VanEck Biotech ETF position peaked at $3.33M in Q3 2016.
  • 31 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.